Penserra Capital Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-332
Closed -$13 984
2016
Q1
$13 Buy
332
+111
+50% +$4 ﹤0.01% 492
2015
Q4
$9K Buy
+221
New +$9K ﹤0.01% 530